反応式
[CH3:1][C:2]1[S:6][C:5]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)=[N:4][C:3]=1[CH2:13][CH2:14][O:15][C:16]1[CH:17]=[C:18]2[C:22](=[CH:23][CH:24]=1)[NH:21][C:20]([C:25]([O:27][CH2:28][CH3:29])=[O:26])=[CH:19]2.C(=O)([O-])[O-].[Cs+].[Cs+].Br[CH2:37][CH:38]1[CH2:42][CH2:41][CH2:40][O:39]1>CN(C)C=O>[CH3:1][C:2]1[S:6][C:5]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)=[N:4][C:3]=1[CH2:13][CH2:14][O:15][C:16]1[CH:17]=[C:18]2[C:22](=[CH:23][CH:24]=1)[N:21]([CH2:37][CH:38]1[CH2:42][CH2:41][CH2:40][O:39]1)[C:20]([C:25]([O:27][CH2:28][CH3:29])=[O:26])=[CH:19]2参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of ethyl 5-[2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethoxy]-1H-indole-2-carboxylate 220 (40.7 mg, 0.100 mmol) in N,N-dimethylformamide (0.9 mL) was added to a stirred mixture of cesium carbonate (325 mg, 1.00 mmol) and 2-(bromomethyl)tetrahydrofuran (19.8 mg, 0.120 mmol) in N,N-dimethylformamide (2.4 mL). The reaction was stirred for 16 h and then the mixture was filtered though a plug (500 mg) of silica gel using ethyl acetate to rinse. The filtrate was concentrated in vacuo and then reverse phase preparative HPLC chromatography gave 19.8 mg of product (retention time=2.4 min.). This material was taken to the next reaction without further purification or analysis.
後処理
- filtrationthe mixture was filtered though a plug (500 mg) of silica gel
- washto rinse
- concentrationThe filtrate was concentrated in vacuo
出典と根拠
- ORDレコード
- ord-731844116c9541c0b2d22f19a11c0e2e
- 出典データセット
- uspto-grants-2004_09
- 特許番号
- US06787651B2
関連ノート
読み込み中…